← Leaderboards
Elaine Arrington Gay
Research Triangle Institute
$1,988,072
Attributed
$3,265,628
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $878.9K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,265,628 · 4
By mechanism
R01$2,555,113 · 1
R03$393,742 · 2
U18$316,773 · 1
Top collaborators
- Christie D Fowler3 shared
Most similar at Research Triangle Institute
Same institution · by research overlap
- Frank I Carroll$18,291,450
- Ojas A. Namjoshi$207,996
- Chunyang Jin$4,561,826
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsIn VitroLigandsCyclic AmpReceptorFamilySignal TransductionG-Protein-Coupled ReceptorsPropertyGpr3 GeneOrphanGpr12 GeneGpr6 GeneNew Therapeutic TargetDrug DiscoveryLeadPathway InteractionsGrantAnalogIn VivoAgonistBiologicalDockingLink
Grant awards (7)
Discovery and development of GPR3 agonists for nicotine cessation$809,519
R01 · FY2025 · DA · contact PI
Discovery and development of GPR3 agonists for nicotine cessation$866,733
R01 · FY2024 · DA · contact PI
Discovery and development of GPR3 agonists for nicotine cessation$878,861
R01 · FY2023 · DA · contact PI
Assay development for characterization of Adrb3 antagonists as pain therapeutics$196,439
R03 · FY2021 · NS · contact PI
Development of GPR3 probes as a novel target for nicotine cessation$316,773
U18 · FY2020 · DA · contact PI
Discovery of GPR6 agonist probes: a novel therapeutic target for drug abuse$103,240
R03 · FY2020 · DA · contact PI
Discovery of GPR6 agonist probes: a novel therapeutic target for drug abuse$94,063
R03 · FY2019 · DA · contact PI